首页> 外国专利> SOURCE SPECIFIC EXOSOMES FOR DETERMINING AVOIDANCE OF CANCER TREATMENT AND AVOIDANCE OF CHECKPOINT INHIBITOR THERAPIES

SOURCE SPECIFIC EXOSOMES FOR DETERMINING AVOIDANCE OF CANCER TREATMENT AND AVOIDANCE OF CHECKPOINT INHIBITOR THERAPIES

机译:用于确定抗癌治疗和避免检查点抑制剂疗法的来源特异性外来肌瘤

摘要

The present disclosure provides methods for predicting and thereby treating cancer or increasing the efficacy of an anti-cancer medication, in part by measuring checkpoint proteins on extracellular vesicles released from non-cancer cells. These checkpoint proteins promote cancer progression and/or compensate for the loss of signal from the checkpoint proteins being inhibited by the checkpoint inhibitory therapy. Compositions and methods of treatment are also provided.
机译:本公开提供了用于预测的方法,从而通过测量从非癌细胞释放的细胞外囊泡上的检查点蛋白,从而提高癌症或增加抗癌药物的功效。这些检查点蛋白促进癌症进展和/或补偿来自检查点抑制治疗的检查点蛋白的信号丧失。还提供了组合物和治疗方法。

著录项

  • 公开/公告号WO2021142088A1

    专利类型

  • 公开/公告日2021-07-15

    原文格式PDF

  • 申请/专利权人 THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA;

    申请/专利号WO2021US12452

  • 发明设计人 GUO WEI;WU BIN;

    申请日2021-01-07

  • 分类号A61K39;A61K39/395;A61K45/06;C07K16/42;C12Q1/6869;

  • 国家 US

  • 入库时间 2022-08-24 19:58:04

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号